Ligand Pharma (LGND) Misses Q1 EPS by 21c
Tweet
Share
E-mailGet Alerts LGND Hot Sheet
Price: $283.84 -0.09%
EPS Growth %: -24.9%
Financial Fact:
Total other income (expense), net: -4.26M
Today's EPS Names:
PMCB, PLCE, DOMO, More
EPS Growth %: -24.9%
Financial Fact:
Total other income (expense), net: -4.26M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Join SI Premium – FREE
Ligand Pharma (NASDAQ: LGND) reported Q1 EPS of $1.63, $0.21 worse than the analyst estimate of $1.84. Revenue for the quarter came in at $51.72 million versus the consensus estimate of $59.07 million.
For earnings history and earnings-related data on Ligand Pharma (LGND) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Hawaiian Electric trades at 8.8x P/E, but wildfire risk clouds value case
- Increasing unusual option volume: GPRO ALMS DPRO FRVO DUST HWM NVS CRK EIX
- Medtronic jumps on earnings beat and raised guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
